BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2147199)

  • 1. Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol.
    Kalish RS; Johnson KL
    J Immunol; 1990 Dec; 145(11):3706-13. PubMed ID: 2147199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urushiol (poison ivy)-triggered suppressor T cell clone generated from peripheral blood.
    Kalish RS; Morimoto C
    J Clin Invest; 1988 Sep; 82(3):825-32. PubMed ID: 2458387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing of urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to T cells in vitro.
    Kalish RS; Wood JA; LaPorte A
    J Clin Invest; 1994 May; 93(5):2039-47. PubMed ID: 7910172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of human T-lymphocyte clones to study T-cell function in allergic contact dermatitis to urushiol.
    Kalish RS
    J Invest Dermatol; 1990 Jun; 94(6 Suppl):108S-111S. PubMed ID: 1693644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation and cloning of human urushiol specific peripheral blood T-cells: isolation of urushiol triggered suppressor T-cells.
    Kalish RS; Morimoto C
    J Invest Dermatol; 1989 Jan; 92(1):46-52. PubMed ID: 2521239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on poison ivy. In vitro lymphocyte transformation by urushiol-protein conjugates.
    Dupuis G
    Br J Dermatol; 1979 Dec; 101(6):617-24. PubMed ID: 161173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies of poison oak immunity. I. In vitro reaction of human lymphocytes to urushiol.
    Byers VS; Epstein WL; Castagnoli N; Baer H
    J Clin Invest; 1979 Nov; 64(5):1437-48. PubMed ID: 315414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies of poison oak immunity. II. Effect of urushiol analogues on the human in vitro response.
    Byers VS; Castagnoli N; Epstein WL
    J Clin Invest; 1979 Nov; 64(5):1449-56. PubMed ID: 315415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A murine model system for contact sensitization to poison oak or ivy urushiol components.
    Dunn IS; Liberato DJ; Dennick RG; Castagnoli N; Byers VS
    Cell Immunol; 1982 Apr; 68(2):377-88. PubMed ID: 6178516
    [No Abstract]   [Full Text] [Related]  

  • 10. Occupational poison ivy and oak dermatitis.
    Epstein WL
    Dermatol Clin; 1994 Jul; 12(3):511-6. PubMed ID: 7923948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of hapten-specific tolerance of human CD8+ urushiol (poison ivy)-reactive T lymphocytes.
    Kalish RS; Wood JA
    J Invest Dermatol; 1997 Mar; 108(3):253-7. PubMed ID: 9036920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single dose parenteral hyposensitization to poison ivy urushiol in guinea pigs.
    Walker LA; Watson ES; elSohly MA
    Immunopharmacol Immunotoxicol; 1995 Aug; 17(3):565-76. PubMed ID: 8576546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of poison ivy/oak allergic contact dermatitis with an extract of jewelweed.
    Long D; Ballentine NH; Marks JG
    Am J Contact Dermat; 1997 Sep; 8(3):150-3. PubMed ID: 9249283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergic contact dermatitis caused by Lithraea molleoides and Lithraea brasiliensis: identification and characterization of the responsible allergens.
    Alé SI; Ferreira F; González G; Epstein W
    Am J Contact Dermat; 1997 Sep; 8(3):144-9. PubMed ID: 9249282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of poison ivy/oak-induced contact sensitivity by treatment with a class II MHC binding peptide:hapten conjugate.
    Gelber C; Gemmell L; McAteer D; Homola M; Swain P; Liu A; Wilson KJ; Gefter M
    J Immunol; 1997 Mar; 158(5):2425-34. PubMed ID: 9036993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in the pathogenesis of allergic contact dermatitis.
    Kalish RS
    Arch Dermatol; 1991 Oct; 127(10):1558-63. PubMed ID: 1929465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyposensitization to poison ivy after working in a cashew nut shell oil processing factory.
    Reginella RF; Fairfield JC; Marks JG
    Contact Dermatitis; 1989 Apr; 20(4):274-9. PubMed ID: 2526711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome profiling reveals Th2 bias and identifies endogenous itch mediators in poison ivy contact dermatitis.
    Liu B; Tai Y; Liu B; Caceres AI; Yin C; Jordt SE
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic studies of poisonous Anacardiaceae: I. Production of tolerance and desensitization to poison Ivy and oak urushiols using esterified urushiol derivatives in guinea pigs.
    Watson ES; Murphy JC; Wirth PW; Waller CW; Elsohly MA
    J Invest Dermatol; 1981 Mar; 76(3):164-70. PubMed ID: 6453903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the mango-poison ivy connection: the riddle of discriminative plant dermatitis.
    Hershko K; Weinberg I; Ingber A
    Contact Dermatitis; 2005 Jan; 52(1):3-5. PubMed ID: 15701120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.